Moffitt: Radiation therapy with pembrolizumab, bevacizumab safe for glioma patients

(H. Lee Moffitt Cancer Center & Research Institute) Moffitt Cancer Center will present preliminary results from a phase 1 study testing whether the addition of pembrolizumab to radiation therapy and bevacizumab is safe and can control tumor growth for these patients.